Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial
Chih-Hsien Chuang, Chung‐Guei Huang, Ching‐Tai Huang, Yi-Ching Chen, Yu-An Kung, Chih‐Jung Chen, Tzu-Chun Chuang, Ching-Chi Liu, Po‐Wei Huang, Shu-Li Yang, Po‐Wen Gu, Shin‐Ru Shih, Cheng‐Hsun Chiu
Topics & Concepts
ReactogenicityImmunogenicityMedicineVaccinationTiterNeutralizing antibodyBooster (rocketry)Booster doseHeterologousVirologyAntibodyClinical trialImmunologyInternal medicineBiologyAstronomyPhysicsGeneBiochemistrySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies